EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications

Vera Malheiro, Joana Duarte, Francisco Veiga, Filipa Mascarenhas-Melo iD

Pharmaceutics · 28.10.2023 · 15 (11) · 2545

DOI: 10.3390/pharmaceutics15112545 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 28.10.2023. Verfasst von Vera Malheiro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Development and Technology Laboratory, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmaceutical industry has entered an era of transformation with the emergence of Pharma 4.0, which leverages cutting-edge technologies in manufacturing processes. These hold tremendous potential for enhancing the overall efficiency, safety, and quality of non-biological complex drugs (NBCDs), a category of pharmaceutical products that pose unique challenges due to their intricate composition and complex manufacturing requirements. This review attempts to provide insight into the application of select Pharma 4.0 technologies, namely machine learning, in silico modeling, and 3D printing, in the manufacturing process of NBCDs. Specifically, it reviews the impact of these tools on NBCDs such as liposomes, polymeric micelles, glatiramer acetate, iron carbohydrate complexes, and nanocrystals. It also addresses regulatory challenges associated with the implementation of these technologies and presents potential future perspectives, highlighting the incorporation of digital twins in this field of research as it seems to be a very promising approach, namely for the optimization of NBCDs manufacturing processes.

Schlagwörter

Stichwörter der Autor:innen

Pharma 4.0digital twinsin silico modelingmachine learningnon-biological complex drugsthree-dimensional (3D) printing

Autor:innen und Institutionen

  • Drug Development and Technology Laboratory, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
  • LAQV, REQUIMTE, Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal.
  • Higher School of Health, Polytechnic Institute of Guarda, Rua da Cadeia, 6300-307 Guarda, Portugal.

ORCID-Profile: Filipa Mascarenhas-Melo

Zitieren

APA

Malheiro, V., Duarte, J., Veiga, F., & Mascarenhas-Melo, F. (2023). Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications. Pharmaceutics, 15(11), 2545. https://doi.org/10.3390/pharmaceutics15112545

Vancouver

Malheiro V, Duarte J, Veiga F, Mascarenhas-Melo F. Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications. Pharmaceutics. 2023;15(11):2545. doi:10.3390/pharmaceutics15112545

BibTeX
@article{Malheiro2023,
  author = {Malheiro, Vera and Duarte, Joana and Veiga, Francisco and Mascarenhas-Melo, Filipa},
  title = {Exploiting Pharma 4.0 Technologies in the Non-Biological Complex Drugs Manufacturing: Innovations and Implications},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {11},
  pages = {2545},
  doi = {10.3390/pharmaceutics15112545}
}
Kostenlos starten →